Back
CytomX Therapeutics Vs. Bristol-Myers Squibb Industry Stock Comparison
Sell
15
CTMX
CytomX Therapeutics
Last Price:
2.00
Seasonality Move:
-12.9%
Sell
37
BMY
Bristol-Myers Squibb
Last Price:
44.12
Seasonality Move:
-0.39%
Sell
15
CytomX Therapeutics (CTMX)
is a Sell
Is CytomX Therapeutics a Buy, Sell or Hold?
- The current CytomX Therapeutics [CTMX] share price is $1.96. The Score for CTMX is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- CTMX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $44.55. The Score for BMY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CTMX Stock Price Chart
What is CytomX Therapeutics's stock price today?
-
The CytomX Therapeutics share price today is $1.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTMX is experiencing slight selling pressure.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $44.55
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMY is experiencing selling pressure, which indicates risk of future bearish movement.
CTMX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 43.17 | Sell |
Chaikin Money Flow: | -971766 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.3 - 3.6) | Sell |
Bollinger Bands (100): | (1.29 - 2.71) | Sell |
BMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.34 | Sell |
Relative Strength Index (14 RSI): | 35.6 | Sell |
Chaikin Money Flow: | -10825897 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.94 - 48.2) | Sell |
Bollinger Bands (100): | (47.09 - 52.55) | Sell |
CTMX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.81 | Sell |
20-day SMA: | 2.57 | Sell |
50-day SMA: | 2.32 | Sell |
200-day SMA: | 1.68 | Buy |
8-day EMA: | 2.46 | Sell |
20-day EMA: | 2.58 | Sell |
50-day EMA: | 2.35 | Sell |
200-day EMA: | 1.9 | Buy |
BMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.45 | Buy |
20-day SMA: | 45.49 | Sell |
50-day SMA: | 49.27 | Sell |
200-day SMA: | 52.91 | Sell |
8-day EMA: | 44.65 | Sell |
20-day EMA: | 45.64 | Sell |
50-day EMA: | 47.83 | Sell |
200-day EMA: | 53.18 | Sell |
CytomX Therapeutics Earnings Growth & CTMX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.02 per share, and a decrease next year of $0.51 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.22 per share, a decrease this year of $6.86 per share, and an increase next year of $6.41 per share.
CytomX Therapeutics Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bristol-Myers Squibb Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |